Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma
The complexity of the pathogenetic mechanisms of the development of chronic inflammation in asthma determines its heterogeneity and insufficient treatment effectiveness. Nuclear transcription factors, which include peroxisome proliferator-activated receptors, that is, PPARs, play an important role i...
Saved in:
| Main Authors: | Oxana Yu. Kytikova, Juliy M. Perelman, Tatyana P. Novgorodtseva, Yulia K. Denisenko, Viktor P. Kolosov, Marina V. Antonyuk, Tatyana A. Gvozdenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2020/8906968 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of neurotrophic growth factors in the pathophysiology of bronchial asthma associated with obesity
by: O. Yu. Kytikova, et al.
Published: (2021-04-01) -
Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
by: Laurent Dubuquoy, et al.
Published: (2009-01-01) -
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders
by: Min-Chul Cho, et al.
Published: (2008-01-01) -
Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-γ: Therapeutic Implications for Cardiovascular Diseases
by: Florence Gizard, et al.
Published: (2008-01-01) -
BDNF/TrkB signaling in stable coronary artery disease
by: O. V. Atamas, et al.
Published: (2023-12-01)